Wintermin en es it fr

Wintermin Brand names, Wintermin Analogs

Wintermin Brand Names Mixture

  • No information avaliable

Wintermin Chemical_Formula

C17H20N2S

Wintermin RX_link

No information avaliable

Wintermin fda sheet

Wintermin msds (material safety sheet)

Wintermin Synthesis Reference

No information avaliable

Wintermin Molecular Weight

284.42 g/mol

Wintermin Melting Point

< 25 oC

Wintermin H2O Solubility

14.2 mg/L

Wintermin State

Liquid

Wintermin LogP

4.893

Wintermin Dosage Forms

Tablet; Oral liquid; Injection

Wintermin Indication

Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.

Wintermin Pharmacology

Promazine belongs to a group of medications known as the phenothiazine antipsychotics. It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Promazine hydrochloride blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. Promazine has weak extrapyramidal and autonomic side effects which lead to its use in the elderly, for restless or psychotic patients. Its anti-psychotic effect is also weaker and it is not useful in general psychiatry.

Wintermin Absorption

Absorption may be erratic and peak plasma concentrations show large interindividual differences.

Wintermin side effects and Toxicity

Side effects include: extrapyramidal symptoms, drowsiness, weight gain, dry mouth, constipation, endocrine effects (such as gynaecomastia and menstrual disturbance), sensitivity to sunlight and haemolytic anaemia.

Wintermin Patient Information

No information avaliable

Wintermin Organisms Affected

Humans and other mammals